Brian A. Van Tine
St. Louis Children's Hospital(US)Washington University in St. Louis(US)University of Washington Medical Center(US)Midwest Therapeutic Endoscopy(US)University Hospitals Seidman Cancer Center(US)Cancer Research Center(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, CAR-T cell therapy research, Cancer, Hypoxia, and Metabolism, Neuroblastoma Research and Treatments, Cancer Research and Treatments
Most-Cited Works
- → Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial(2017)1,375 cited
- → Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial(2016)584 cited
- → Sorafenib for Advanced and Refractory Desmoid Tumors(2018)434 cited
- → Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study(2020)389 cited
- → Cell cycle–regulated phosphorylation of p220NPATby cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription(2000)378 cited
- → Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial